Ferro M, Tataru O, Musi G, Lucarelli G, Abu Farhan A, Cantiello F
    
    
    Diagnostics (Basel). 2022; 12(3).
  
  
    PMID: 35328139
    
          PMC: 8947693.
    
          DOI: 10.3390/diagnostics12030586.
      
 
                                  
  
    Yang Z, Bai Y, Hu X, Wang X, Han P
    
    
    Dose Response. 2021; 18(4):1559325820979247.
  
  
    PMID: 33402880
    
          PMC: 7745568.
    
          DOI: 10.1177/1559325820979247.
      
 
                                  
  
    Ferro M, Vartolomei M, Russo G, Cantiello F, Abu Farhan A, Terracciano D
    
    
    World J Urol. 2018; 37(3):507-514.
  
  
    PMID: 29992381
    
    
          DOI: 10.1007/s00345-018-2397-1.
      
 
                                  
  
    Barnes T, Amir E
    
    
    Br J Cancer. 2017; 117(4):451-460.
  
  
    PMID: 28704840
    
          PMC: 5558691.
    
          DOI: 10.1038/bjc.2017.220.
      
 
                                  
  
    Tian Y, Ma Z, Chen Z, Li M, Wu Z, Hong M
    
    
    PLoS One. 2016; 11(7):e0158891.
  
  
    PMID: 27410033
    
          PMC: 4943634.
    
          DOI: 10.1371/journal.pone.0158891.
      
 
                              
              
                              
                                      
  Preoperative Glasgow prognostic score as a predictor of primary bladder cancer recurrence.
  
    Yuksel O, Akan S, Urkmez A, Yildirim C, Sahin A, Verit A
    
    
    Mol Clin Oncol. 2016; 5(1):201-206.
  
  
    PMID: 27330798
    
          PMC: 4906850.
    
          DOI: 10.3892/mco.2016.901.
      
 
                                          
                                                          
  Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
  
    Dabi Y, Rouscoff Y, Anract J, Barry Delongchamps N, Sibony M, Saighi D
    
    
    World J Urol. 2016; 35(2):229-235.
  
  
    PMID: 27272203
    
    
          DOI: 10.1007/s00345-016-1852-0.
      
 
                                          
                                                          
  High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.
  
    Luo Y, Zhang X, Mo M, Tan Z, Huang L, Zhou H
    
    
    Medicine (Baltimore). 2016; 95(15):e3337.
  
  
    PMID: 27082587
    
          PMC: 4839831.
    
          DOI: 10.1097/MD.0000000000003337.
      
 
                                          
                                                          
  Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
  
    Ferro M, de Cobelli O, Buonerba C, Di Lorenzo G, Capece M, Bruzzese D
    
    
    Medicine (Baltimore). 2015; 94(42):e1861.
  
  
    PMID: 26496339
    
          PMC: 4620818.
    
          DOI: 10.1097/MD.0000000000001861.
      
 
                                          
                                                          
  Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
  
    Zhou L, Cai X, Liu Q, Jian Z, Li H, Wang K
    
    
    Sci Rep. 2015; 5:12733.
  
  
    PMID: 26235332
    
          PMC: 4522672.
    
          DOI: 10.1038/srep12733.
      
 
                                          
                                                          
  Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection.
  
    Pastore A, Palleschi G, Fuschi A, Silvestri L, Al Salhi Y, Costantini E
    
    
    BMC Cancer. 2015; 15:120.
  
  
    PMID: 25877676
    
          PMC: 4369111.
    
          DOI: 10.1186/s12885-015-1152-x.
      
 
                                          
                                                          
  Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor.
  
    Josa V, Krzystanek M, Vass T, Lang T, Juhasz V, Szilagyi K
    
    
    Pathol Oncol Res. 2015; 21(4):991-7.
  
  
    PMID: 25761795
    
    
          DOI: 10.1007/s12253-015-9925-8.
      
 
                                          
                                                          
  A prospective study of the role of inflammation in bladder cancer.
  
    Qayyum T, McArdle P, Hilmy M, Going J, Orange C, Seywright M
    
    
    Curr Urol. 2014; 6(4):189-93.
  
  
    PMID: 24917741
    
          PMC: 3783284.
    
          DOI: 10.1159/000343537.
      
 
                                          
                                                          
  Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.
  
    Pinato D, Shiner R, Seckl M, Stebbing J, Sharma R, Mauri F
    
    
    Br J Cancer. 2014; 110(8):1930-5.
  
  
    PMID: 24667648
    
          PMC: 3992503.
    
          DOI: 10.1038/bjc.2014.145.
      
 
                                          
                                                          
  Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver.
  
    Kim D, Chung J, Yoon J, Ha Y, Bae S, Lee E
    
    
    J Ginseng Res. 2013; 37(1):54-63.
  
  
    PMID: 23717157
    
          PMC: 3659628.
    
          DOI: 10.5142/jgr.2013.37.54.
      
 
                                          
                                                          
  Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.
  
    Tadin T, Krpina K, Stifter S, Babarovic E, Fuckar Z, Jonjic N
    
    
    Diagn Pathol. 2012; 7:152.
  
  
    PMID: 23126361
    
          PMC: 3527228.
    
          DOI: 10.1186/1746-1596-7-152.
      
 
                                          
                                                          
  First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival.
  
    Otto W, Denzinger S, Wieland W, Hartmann A
    
    
    World J Urol. 2012; 30(6):875-7.
  
  
    PMID: 23097035
    
    
          DOI: 10.1007/s00345-012-0974-2.
      
 
                                          
                                                          
  Cyclooxygenase-2 expression in bladder cancer and patient prognosis: results from a large clinical cohort and meta-analysis.
  
    Czachorowski M, Amaral A, Montes-Moreno S, Lloreta J, Carrato A, Tardon A
    
    
    PLoS One. 2012; 7(9):e45025.
  
  
    PMID: 23028744
    
          PMC: 3441520.
    
          DOI: 10.1371/journal.pone.0045025.
      
 
                                          
                                                          
  Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy.
  
    Denkert C, Darb-Esfahani S, Loibl S, Anagnostopoulos I, Johrens K
    
    
    Semin Immunopathol. 2011; 33(4):341-51.
  
  
    PMID: 21499853
    
    
          DOI: 10.1007/s00281-011-0261-0.
      
 
                                          
                                                          
  The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.
  
    Kasymjanova G, Macdonald N, Agulnik J, Cohen V, Pepe C, Kreisman H
    
    
    Curr Oncol. 2010; 17(4):52-8.
  
  
    PMID: 20697515
    
          PMC: 2913830.
    
          DOI: 10.3747/co.v17i4.567.